Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $13.47 in the prior trading day, Syndax Pharmaceuticals Inc (NASDAQ: SNDX) closed at $13.93, up 3.41%. In other words, the price has increased by $3.41 from its previous closing price. On the day, 3.36 million shares were traded. SNDX stock price reached its highest trading level at $14.12 during the session, while it also had its lowest trading level at $13.26.
Ratios:
Our goal is to gain a better understanding of SNDX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.99 and its Current Ratio is at 6.99. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $37.
On June 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $37.
Scotiabank Downgraded its Sector Outperform to Sector Perform on January 31, 2024, whereas the target price for the stock was revised from $36 to $23.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 14 ’24 when Goldan Keith A. bought 1,250 shares for $20.03 per share. The transaction valued at 25,037 led to the insider holds 52,623 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNDX now has a Market Capitalization of 1189032704 and an Enterprise Value of 783491392. For the stock, the TTM Price-to-Sale (P/S) ratio is 76.85 while its Price-to-Book (P/B) ratio in mrq is 3.25. Its current Enterprise Value per Revenue stands at 48.968 whereas that against EBITDA is -2.439.
Stock Price History:
Over the past 52 weeks, SNDX has reached a high of $25.34, while it has fallen to a 52-week low of $13.32. The 50-Day Moving Average of the stock is -22.00%, while the 200-Day Moving Average is calculated to be -31.28%.
Shares Statistics:
The stock has traded on average 1.50M shares per day over the past 3-months and 2050600 shares per day over the last 10 days, according to various share statistics. A total of 85.57M shares are outstanding, with a floating share count of 81.08M. Insiders hold about 5.02% of the company’s shares, while institutions hold 100.30% stake in the company. Shares short for SNDX as of 1732838400 were 14396481 with a Short Ratio of 9.58, compared to 1730332800 on 10657597. Therefore, it implies a Short% of Shares Outstanding of 14396481 and a Short% of Float of 17.0.
